Financial Results Nine month period 2019 - Video

Javier López-Belmonte, Vicepresident and CFO of Laboratorios Farmacéuticos ROVI presents the financial results for the first nine months of 2019.


No votes yet
 
Related
Laboratorios Farmacéuticos Rovi, S.A. announces that ROIS Phoenix Inc. (the “Buyer”), a wholly owned subsidiary of ROVI Pharma Industrial...
1 min
29/09/2025
​Operating revenue in the first half of 2025 was 314.6 million euros, a 4% decrease on the first half of 2024, mainly due to the...
3 min
24/07/2025
  Madrid, 10 July 2025. Laboratorios Farmacéuticos ROVI, S.A. (“ROVI”) announces that, on 9 July 2025, the Technological...
4 min
10/07/2025